Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Stock
Equities
600329
CNE000001808
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
34.99 CNY | +3.46% | +1.80% | +3.98% |
Apr. 30 | Tianjin Pharmaceutical's Q1 Profit, Revenue Fall 3% | MT |
Apr. 30 | Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Recommends Dividend | CI |
Sales 2024 * | 9.05B 1.25B | Sales 2025 * | 9.96B 1.38B | Capitalization | 22.82B 3.15B |
---|---|---|---|---|---|
Net income 2024 * | 1.17B 162M | Net income 2025 * | 1.4B 193M | EV / Sales 2024 * | 2.52 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.29 x |
P/E ratio 2024 * |
23
x | P/E ratio 2025 * |
19.3
x | Employees | 4,619 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 31.14% |
1 day | +3.46% | ||
1 week | +1.80% | ||
1 month | +14.12% | ||
3 months | +40.98% | ||
6 months | +18.89% | ||
Current year | +3.98% |
Managers | Title | Age | Since |
---|---|---|---|
Lei Wang
CEO | Chief Executive Officer | 53 | 22-08-21 |
Hong Zhou
CTO | Chief Tech/Sci/R&D Officer | 54 | 12-11-30 |
42 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ping Zhang
BRD | Director/Board Member | 55 | 19-09-29 |
Yoke Pheng Liew
BRD | Director/Board Member | 68 | 20-06-04 |
Hong Zhou
CTO | Chief Tech/Sci/R&D Officer | 54 | 12-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +2.67% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 34.99 | +3.46% | 10,997,190 |
24-04-29 | 33.82 | -1.60% | 9,468,535 |
24-04-26 | 34.37 | +2.26% | 8,513,755 |
24-04-25 | 33.61 | +0.09% | 5,878,664 |
End-of-day quote Shanghai S.E., April 29, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.98% | 3.15B | |
+39.33% | 6.11B | |
-18.38% | 4.35B | |
-9.17% | 3.19B | |
-3.41% | 2.51B | |
+48.74% | 1.98B | |
-4.82% | 1.74B | |
-1.24% | 1.63B | |
-8.96% | 1.6B | |
+39.87% | 1.45B |
- Stock Market
- Equities
- 600329 Stock